News & Opinion
Top 10 Innovations
Cell & Molecular Biology
Disease & Medicine
Ecology & Environment
Genetics & Genomics
Pharma & Biotech
Image of the Day
Bt Corn Associated with Higher Yields, Less Insecticide Use in Neighboring Fields
Shawna Williams | Mar 13, 2018
An analysis of 40 years of data also finds declines in pest populations after the introduction of the GM crop.
Russian Sites Promote Anti-GMO Articles, Study Finds
Jim Daley | Feb 28, 2018
publish stories about GMOs more often than US outlets, and typically portray them in a negative light.
EU Advisor Recommends Regulatory Exemption for Gene Editing
Catherine Offord | Jan 18, 2018
Crops produced using mutagenic technologies such as CRISPR should generally be exempt from regulatory laws governing GMOs, according to the published opinion.
Insects Are Increasingly Evolving Resistance to Genetically Modified Crops
Ashley P. Taylor | Oct 13, 2017
Plantings of non-GM refuges counter the development of resistance.
GM Mosquitoes Closer to Release in U.S.
Abby Olena | Oct 13, 2017
The EPA is now in charge of regulating the use of Oxitec’s strain of
, genetically engineered to reduce populations of the insects.
Texas Considers GM Mosquitoes
Kerry Grens | Mar 28, 2017
In an effort to prevent the spread of Zika virus, Harris County officials are in discussions with Oxitec to release insects engineered to produce short-lived offspring.
Monsanto and Bayer Announce Approval of Massive Merger
Bob Grant | Dec 13, 2016
On Tuesday, shareholders at the agribusiness giant approved the $66 billion deal with the European pharmaceutical firm.
Science History: The First Transgenic
Kerry Grens | Oct 1, 2016
Tweaks to a transformation protocol in 1986 cemented the little plant's mighty role in plant genetics research.
Monsanto Buys Rights to CRISPR
Jef Akst | Sep 27, 2016
The US agribusiness secures a global, nonexclusive licensing agreement from the Broad Institute to use the gene-editing technology for agricultural applications.
Bayer Looks to Buy Monsanto
Bob Grant | Sep 14, 2016
The US agribusiness behemoth agreed to a $57 billion buyout offer from the European pharmaceutical giant.